BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Development of a standard rapid Auditory Brainstem Response External Quality Assurance (ABR EQA) scheme focused on ABR traces only in partnership with Gen QA (consortium with NEQAS and the National Physical Laboratory), to facilitate national and regional ABR EQA and provide an improved measure and assurance of testing performance.
The recent review into paediatric audiology within England has shown a significant gap in ABR testing, both in terms of knowledge in performing the test and in quality assurance of the testing. At the present time, the only form of quality assurance for ABR testing is through peer review. There is no national external quality assessment scheme. ABR peer review, is sporadic across the country, with a number of different groups across each area. The quality of these groups is variable, with differing governance structures and no consistent criteria for which cases are selected for review. Participation, desp
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| GENQA LTD | SC639731 | £280,000 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Awarded To | Status |
|---|---|---|---|
| Lot 1 | £280,000 initial term | GENQA LTD | active |
Government spending data: This supplier has received £662,393 in 1 payments (over £25k) from UK Health Security Agency (2022-04-22 to 2022-04-22). View full payment history →